Literature DB >> 16380241

Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.

Rouslan I Moustafine1, Igor M Zaharov, Vera A Kemenova.   

Abstract

The formation of interpolyelectrolyte complexes (IPEC) between Eudragit E PO (EE) and Eudragit L 100-55 (EL) was investigated, using turbidimetry, apparent viscosity measurements, elementary analysis and MT-DSC. The structure of the synthesized IPEC was investigated using FT-IR spectroscopy. The binding ratio of a unit molecule of EL with EE was found to be approximately 1:1 at pH 5.5. Based on the results of elementary analysis and FT-IR, the binding ratio of each component in the solid complexes was very close to that observed in turbidity and apparent viscosity measurements and indicate that the synthesized products can be considered as IPEC. As a result of electrostatic interaction between the polymer chains, the glass transition temperature of the IPEC increased significantly. Due to the structure of the IPEC, two maxima were observed in the swelling behavior as a function of pH. The release of the model drug ibuprofen (IBF) was significantly retarded from tablets made up of the IPEC as compared with individual copolymers, its physical mixture and Eudragit RL PO (RL), RS PO (RS).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380241     DOI: 10.1016/j.ejpb.2005.10.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  12 in total

1.  Carrageenans from Sarcothalia crispata and Gigartina skottsbergii: Structural Analysis and Interpolyelectrolyte Complex Formation for Drug Controlled Release.

Authors:  Melanie Hebe Hughes; Héctor Juan Prado; María Cecilia Rodríguez; Karina Michetti; Patricia Inés Leonardi; María Cristina Matulewicz
Journal:  Mar Biotechnol (NY)       Date:  2018-07-09       Impact factor: 3.619

2.  Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.

Authors:  Balamurugan Jeganathan; Vijayalakshmi Prakya
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

3.  Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets.

Authors:  Ahmad Bani-Jaber; Leena Al-Aani; Hatim Alkhatib; Bashar Al-Khalidi
Journal:  AAPS PharmSciTech       Date:  2011-02-08       Impact factor: 3.246

4.  Sustained release tablets containing soluble polymethacrylates: comparison with tableted polymethacrylate IPEC polymers.

Authors:  Wasfy M Obeidat; Alaa H Abuznait; Al-Sayed A Sallam
Journal:  AAPS PharmSciTech       Date:  2010-01-07       Impact factor: 3.246

5.  Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery.

Authors:  Gurpreet Kaur; Subheet Jain; Ashok K Tiwary
Journal:  Sci Pharm       Date:  2009-12-03

6.  In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets.

Authors:  Tamal Krishna Deb; B Ramireddy; Afrasim Moin; H G Shivakumar
Journal:  Int J Pharm Investig       Date:  2015 Jan-Mar

7.  Clavanin bacterial sepsis control using a novel methacrylate nanocarrier.

Authors:  Amanda C M Saúde; Alicia S Ombredane; Osmar N Silva; João A R G Barbosa; Susana E Moreno; Ana Claudia Guerra Araujo; Rosana Falcão; Luciano P Silva; Simoni C Dias; Octávio L Franco
Journal:  Int J Nanomedicine       Date:  2014-10-31

8.  Intestinal mucoadhesive devices for oral delivery of insulin.

Authors:  Amrita Banerjee; JooHee Lee; Samir Mitragotri
Journal:  Bioeng Transl Med       Date:  2016-08-19

9.  Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes.

Authors:  Kenneth Chibuzor Ofokansi; Franklin Chimaobi Kenechukwu
Journal:  ISRN Pharm       Date:  2013-08-06

10.  Eudragit: A Novel Carrier for Controlled Drug Delivery in Supercritical Antisolvent Coprecipitation.

Authors:  Paola Franco; Iolanda De Marco
Journal:  Polymers (Basel)       Date:  2020-01-18       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.